Carolien Zeetsen

144 Gur, R., Richard, J., Calkins, M., Chiavacci, R., Hansen, J., Bilker, W., Loughead, J., Connolly, J., Qiu, H., Mentch, F., Abou–Sleiman, P., Hakonarson, H., & Gur, R.E. (2012). Age group and sex differences in performance on a computerized neurocognitive battery in children age 8–21. Neuropsychology, 26 (2), 251–265. https://doi.org/10.1037/a0026712 Hagen, E., Sømhovd, M., Hesse, M., Arnevik, E.A., & Erga, A.H. (2019). Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF–A – The significance of psychiatric symptoms. Journal of Substance Abuse Treatment, 97 , 21–27. https://doi.org/10.1016/j. jsat.2018.11.010 Hammes, J.G.W. (1971). De Stroop Kleur–Woord Test: handleiding [The Stroop Colour–Word Test: manual]. Lisse, The Netherlands, Swets en Zeitlinger. Heirene, R., John, B., & Roderique–Davies, G. (2018). Identification and evaluation of neuropsychological tools used in the assessment of alcohol–related cognitive impairment: a systematic review. Frontiers in Psychology, 9 (2618), 1–42. https://doi.org/10.3389/fpsyg.2018.02618 Hellebrekers, D., Winkens, I., Kruiper, S., & Van Heugten, C.M. (2017). Psychometric properties of the awareness questionnaire, patient competency rating scale and dysexecutive questionnaire in patients with acquired brain injury. Brain Injury, 31 (11), 1469–1478. https://doi.org/10.1080/0269 9052.2017.1377350 Hoaglin, D.C., & Iglewicz, B. (1987). Fine–tuning some resistant rules for outlier labeling. Journal of the American Statistical Association, 82 (400), 1147–1149. https://doi.org/10.2307/2289392 van Holst, R.J., & Schilt, T. (2011). Drug–related decrease in neuropsychological functions of abstinent drug users. Current Drug Abuse Reviews, 4 (1), 42–56. https://doi.org/10.2174/1874473711104010042 Horner, M.D., Harvey, R.T., & Denier, C.A. (1999). Self–report and objective measures of cognitive deficit in patients entering substance abuse treatment. Psychiatry Research, 86 (2), 155–161. https://doi. org/10.1016/S0165-1781(99)00031-1 Iudicello, J.E., Woods, S.P., Vigil, O., Scott, J.C., Cherner, M., Heaton, R.K., Atkinson, J.H., Grant, I., & The HIV Neurobehavioral Recearch Center (HNRC) Group. (2010). Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence. Journal of Clinical and Experimental Neuropsychology, 32 (7), 704–718. https:// doi.org/10.1080/13803390903512637 Jacobs, A., Stalpers–Konijnenburg, S.C., de Jong, C.A.J., & Marijnissen, R.M. (2016). Chronic stimulant use: an upcoming cause of neurocognitive disorder in later life? Clinical Medical Reviews and Case Reports, 3 (1), 1–3. https://doi.org/10.23937/2378-3656/1410086 Janssen, M.A.M., Bosch, M., Koopmans, P.P., & Kessels, R.P.C. (2015). Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV–1 infected patients. Journal of Neurovirology, 21 (4), 383–390. https://doi.org/10.1007/s13365-015- 0324-4 Johansson, J., Grönbladh, A., & Hallberg, M. (2014). Gamma–Hydroxybutyrate (GHB) induces cognitive deficits and affects GABA B receptors and IGF–1 receptors in male rats. Behavioural Brain Research, 269 , 164–174. https://doi.org/10.1016/j.bbr.2014.04.034